Infection with murine gammaherpesvirus 68 exacerbates inflammatory bowel disease in IL-10-deficient mice

Inflammation Research

Volumn 58, Issue 12, 2009, Pages 881-889

  Nelson, D A ^a   Petty, C C ^a,b   Bost, Kenneth L ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b PROMEGA CORPORATION   (United States)

Author keywords

Colitis; Gammaherpesvirus; IL 10; Inflammatory bowel disease

Indexed keywords

INTERLEUKIN 10;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL VIABILITY; BACTERIUM DETECTION; BODY WEIGHT; COLITIS; COLON DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; GAMMAHERPESVIRUS 68; HERPES VIRUS; HISTOPATHOLOGY; KNOCKOUT MOUSE; LATENT VIRUS INFECTION; LIVER; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SPLEEN; SPLENOMEGALY; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS LOAD;

ANIMALS; CELL LINE; COLON; HERPESVIRIDAE INFECTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; LEUKOCYTES; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RHADINOVIRUS; SPLEEN; SURVIVAL RATE; VIRAL LOAD; VIRUS LATENCY;

EID: 70449517398     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0059-x     Document Type: Article

References (52)

1. JD Lunemann C Munz 2007 Epstein-Barr virus and multiple sclerosis Curr Neurol Neurosci Rep 7 3 253 258 10.1007/s11910-007-0038-y 17488592 1:CAS:528:DC%2BD2sXptFGqtLs%3D (Pubitemid 46831520)
2. HH Niller H Wolf J Minarovits 2008 Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases Autoimmunity 41 4 298 328 10.1080/08916930802024772 18432410 1:CAS:528:DC%2BD1cXltFCmu7o%3D (Pubitemid 351593860)
3. JW Peacock SF Elsawa CC Petty WF Hickey KL Bost 2003 Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68 Eur J Immunol 33 7 1849 1858 10.1002/eji.200323148 12811845 1:CAS:528:DC%2BD3sXlslWlsLo%3D (Pubitemid 37120856)
4. JB Harley IT Harley JM Guthridge JA James 2006 The curiously suspicious: a role for Epstein-Barr virus in lupus Lupus 15 11 768 777 10.1177/ 0961203306070009 17153849 1:CAS:528:DC%2BD28XhtlGhsLrF
5. KH Costenbader EW Karlson 2006 Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther 8 1 204 10.1186/ar1893 16542469 1:CAS:528:DC%2BD28XhvFWhu7c%3D (Pubitemid 43264492)
6. J Nikolich-Zugich 2008 Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections Nature Rev 8 7 512 522 10.1038/nrc2440 1:CAS:528:DC%2BD1cXnsFOktbw%3D (Pubitemid 351881854)
7. I Saygun A Kubar S Sahin K Sener J Slots 2008 Quantitative analysis of association between herpesviruses and bacterial pathogens in periodontitis J Periodontal Res 43 3 352 359 10.1111/j.1600-0765.2007.01043.x 18086168 1:CAS:528:DC%2BD1cXntFyrtr4%3D
8. J Slots 2004 Herpesviruses, the missing link between gingivitis and periodontitis? J Int Acad Periodontol 6 4 113 119 15553977
9. J Slots 2007 Herpesviral-bacterial synergy in the pathogenesis of human periodontitis Curr Opin Infect Dis 20 3 278 283 10.1097/QCO.0b013e3280964da0 17471038 (Pubitemid 46686010)
10. I Brook 2005 The association of anaerobic bacteria with infectious mononucleosis Anaerobe 11 6 308 311 10.1016/j.anaerobe.2005.04.004 16701590 1:CAS:528:DC%2BD2MXhtVGrtrrM (Pubitemid 41376564)
11. LE Stenfors HM Bye S Raisanen R Myklebust 2000 Bacterial penetration into tonsillar surface epithelium during infectious mononucleosis J Laryngol Otol 114 11 848 852 11144834 1:STN:280:DC%2BD3M7gsFCmug%3D%3D
12. LE Stenfors HM Bye S Raisanen 2002 Causes for massive bacterial colonization on mucosal membranes during infectious mononucleosis: implications for acute otitis media Int J Pediatr Otorhinolaryngol 65 3 233 240 10.1016/S0165-5876(02)00180-5 12242139 (Pubitemid 35299414)
13. K Garimorth J Kountchev R Bellmann B Semenitz G Weiss M Joannidis 2008 Lemierre's syndrome following infectious mononucleosis Wien Klin Wochenschr 120 5-6 181 183 10.1007/s00508-008-0937-1 18365159
14. LB Givner 1992 Arcanobacterium haemolyticum sepsis and Epstein-Barr virus infection Pediatr Infect Dis J 11 5 417 418 1321407 1:STN:280: DyaK38zjsV2gtw%3D%3D
15. TY Yoon TH Yang YS Hahn JR Huh Y Soo 2001 Epstein-Barr virus-associated recurrent necrotic papulovesicles with repeated bacterial infections ending in sepsis and death: consideration of the relationship between Epstein-Barr virus infection and immune defect J Dermatol 28 8 442 447 11560162 1:STN:280:DC%2BD3Mrht1Ghug%3D%3D
16. G Bertalot V Villanacci M Gramegna E Orvieto R Negrini A Saleri, et al. 2001 Evidence of Epstein-Barr virus infection in ulcerative colitis Dig Liver Dis 33 7 551 558 10.1016/S1590-8658(01)80106-7 11816543 1:STN:280: DC%2BD38%2FovVSruw%3D%3D
17. HO Kangro SK Chong A Hardiman RB Heath JA Walker-Smith 1990 A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease Gastroenterology 98 3 549 553 2298361 1:STN:280:DyaK3c7ivVSgsw%3D%3D
18. T Spieker H Herbst 2000 Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease Am J Pathol 157 1 51 57 10880375 1:STN:280:DC%2BD3czptVansQ%3D%3D
19. Y Takeda K Takada H Togashi H Takeda M Sakano Y Osada, et al. 2000 Demonstration of Epstein-Barr virus localized in the colonic and ileal mucosa of a patient with ulcerative colitis Gastrointest Endosc 51 2 205 209 10.1016/S0016-5107(00)70420-2 10650270 1:STN:280:DC%2BD3c7hslOksg%3D%3D
20. HJ Van Kruiningen M Poulin AE Garmendia P Desreumaux JF Colombel G De Hertogh, et al. 2007 Search for evidence of recurring or persistent viruses in Crohn's disease Apmis 115 8 962 968 10.1111/j.1600-0463.2007.apm-564.x 17696953 (Pubitemid 47256282)
21. AJ Wakefield JD Fox AM Sawyerr JE Taylor CH Sweenie M Smith, et al. 1992 Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction J Med Virol 38 3 183 190 10.1002/jmv.1890380306 1287131 1:CAS:528:DyaK3sXhs1Knur4%3D
22. H Yanai N Shimizu S Nagasaki N Mitani K Okita 1999 Epstein-Barr virus infection of the colon with inflammatory bowel disease Am J Gastroenterol 94 6 1582 1586 10.1111/j.1572-0241.1999.01148.x 10364028 1:STN:280: DyaK1M3ptVKqtA%3D%3D (Pubitemid 29260449)
23. JI Cohen 2000 Epstein-Barr virus infection N Engl J Med 343 7 481 492 10.1056/NEJM200008173430707 10944566 1:STN:280:DC%2BD3czpvVWgsA%3D%3D (Pubitemid 30646489)
24. LI Compston F Sarkobie C Li D Candotti O Opare-Sem JP Allain 2008 Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions J Virol Methods 151 1 47 54 10.1016/j.jviromet.2008.03.023 18479760 1:CAS:528: DC%2BD1cXmvFektr8%3D
25. B Cameron M Bharadwaj J Burrows C Fazou D Wakefield I Hickie, et al. 2006 Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load J Infect Dis 193 5 664 671 10.1086/500248 16453261 1:CAS:528:DC%2BD28XitF2ht7c%3D (Pubitemid 43271499)
26. AD Hislop GS Taylor D Sauce AB Rickinson 2007 Cellular responses to viral infection in humans: lessons from Epstein-Barr virus Annu Rev Immunol 25 587 617 10.1146/annurev.immunol.25.022106.141553 17378764 1:CAS:528: DC%2BD2sXltlansrY%3D (Pubitemid 46697918)
27. PC Doherty RA Tripp AM Hamilton-Easton RD Cardin DL Woodland MA Blackman 1997 Tuning into immunological dissonance: an experimental model for infectious mononucleosis [see comments] Curr Opin Immunol 9 4 477 483 10.1016/S0952- 7915(97)80098-2 9287187 1:CAS:528:DyaK2sXlvVykurc%3D (Pubitemid 27392851)
28. E Flano DL Woodland MA Blackman 2002 A mouse model for infectious mononucleosis Immunol Res 25 3 201 217 10.1385/IR:25:3:201 12018460 1:CAS:528:DC%2BD38XjvFGnsLw%3D (Pubitemid 34454712)
29. J Mistrikova H Raslova M Mrmusova M Kudelova 2000 A murine gammaherpesvirus Acta Virol 44 3 211 226 11155368 1:CAS:528:DC%2BD3cXnvVSkurk%3D
30. JP Simas S Efstathiou 1998 Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis Trends Microbiol 6 7 276 282 10.1016/S0966-842X(98)01306-7 9717216 1:STN:280:DyaK1czot12ntg%3D%3D (Pubitemid 28343308)
31. SF Elsawa KL Bost 2004 Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis J Immunol 172 1 516 524 14688362 1:CAS:528:DC%2BD3sXpvFegsr0%3D
32. SF Elsawa W Taylor CC Petty I Marriott JV Weinstock KL Bost 2003 Reduced CTL response and increased viral burden in substance P receptor-deficient mice infected with murine gamma-herpesvirus 68 J Immunol 170 5 2605 2612 12594288 1:CAS:528:DC%2BD3sXht12htL0%3D
33. N Gasper-Smith I Marriott KL Bost 2006 Murine gamma-herpesvirus 68 limits naturally occurring CD4+CD25+T regulatory cell activity following infection J Immunol 177 7 4670 4678 16982906 1:CAS:528:DC%2BD28Xps1Gnsr8%3D
34. N Gasper-Smith S Singh KL Bost 2006 Limited IL-6 production following infection with murine gammaherpesvirus 68 Arch Virol 151 7 1423 1429 10.1007/s00705-006-0725-z 16489506 1:CAS:528:DC%2BD28XmtFGquro%3D (Pubitemid 43962156)
35. JW Peacock KL Bost 2000 Infection of intestinal epithelial cells and development of systemic disease following gastric instillation of murine gammaherpesvirus-68 J Gen Virol 81 Pt 2 421 429 10644841 1:CAS:528: DC%2BD3cXhtVymtLc%3D
36. JW Peacock KL Bost 2001 Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis Immunology 104 1 109 117 10.1046/j.1365-2567.2001.01286.x 11576228 1:CAS:528:DC%2BD3MXnt1ClsLY%3D
37. AK Bhan E Mizoguchi RN Smith A Mizoguchi 1999 Colitis in transgenic and knockout animals as models of human inflammatory bowel disease Immunol Rev 169 195 207 10.1111/j.1600-065X.1999.tb01316.x 10450518 1:STN:280: DyaK1MznvFSisA%3D%3D (Pubitemid 29338733)
38. R Kuhn J Lohler D Rennick K Rajewsky W Muller 1993 Interleukin-10- deficient mice develop chronic enterocolitis Cell 75 2 263 274 10.1016/0092-8674(93)80068-P 8402911 1:STN:280:DyaK2c%2Fgs1Gmug%3D%3D (Pubitemid 23320290)
39. F Powrie H Uhlig 2004 Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease Novartis Found Symp 263 164 174 10.1002/0470090480.ch12 15669641 1:CAS:528:DC%2BD2MXitFCqur0%3D discussion 74-8, 211-8
40. DJ Berg N Davidson R Kuhn W Muller S Menon G Holland, et al. 1996 Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses J Clin Invest 98 4 1010 1020 10.1172/JCI118861 8770874 1:CAS:528:DyaK28XlsFOgt7w%3D
41. BM Dutia DJ Allen H Dyson AA Nash 1999 Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection Virology 261 2 173 179 10.1006/viro.1999.9834 10497103 1:CAS:528:DyaK1MXmtVygsbY%3D (Pubitemid 29431770)
42. MT DeMeo EA Mutlu A Keshavarzian MC Tobin 2002 Intestinal permeation and gastrointestinal disease J Clin Gastroenterol 34 4 385 396 10.1097/00004836- 200204000-00003 11907349 (Pubitemid 34258314)
43. K Karlinger T Gyorke E Mako A Mester Z Tarjan 2000 The epidemiology and the pathogenesis of inflammatory bowel disease Eur J Radiol 35 3 154 167 10.1016/S0720-048X(00)00238-2 11000558 1:STN:280:DC%2BD3M%2FhsFaktA%3D%3D (Pubitemid 30734686)
44. A Swidsinski SP Lee 2001 The role of bacteria in gallstone pathogenesis Front Biosci 6 E93 E103 10.2741/Swidsinski 11578976 1:CAS:528: DC%2BD3MXnsFCnsrw%3D
45. S Zeuzem 2000 Gut-liver axis Int J Colorectal Dis 15 2 59 82 10.1007/s003840050236 10855547 1:STN:280:DC%2BD3cvntlWisg%3D%3D
46. RJ Kennedy M Hoper K Deodhar PJ Erwin SJ Kirk KR Gardiner 2000 Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease Br J Surg 87 10 1346 1351 10.1046/j.1365-2168.2000.01615.x 11044159 1:STN:280:DC%2BD3crgtVGltQ%3D%3D (Pubitemid 30768890)
47. KL Madsen 2001 Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse Clin Invest Med 24 5 250 257 11603509 1:CAS:528: DC%2BD3MXnvFOkt7Y%3D
48. DM Rennick MM Fort 2000 Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation Am J Physiol Gastrointest Liver Physiol 278 6 G829 G833 10859210 1:CAS:528: DC%2BD3cXks1Kntbw%3D
49. J Brimnes J Reimann M Nissen M Claesson 2001 Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease Eur J Immunol 31 1 23 31 10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO;2-2 11169434 1:CAS:528:DC%2BD3MXhtVGrsrg%3D (Pubitemid 32095994)
50. KL Madsen JS Doyle MM Tavernini LD Jewell RP Rennie RN Fedorak 2000 Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice Gastroenterology 118 6 1094 1105 10.1016/S0016-5085(00)70362-3 10833484 1:CAS:528:DC%2BD3cXktlaiurk%3D
51. RK Sellon S Tonkonogy M Schultz LA Dieleman W Grenther E Balish, et al. 1998 Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect Immun 66 11 5224 5231 9784526 1:CAS:528:DyaK1cXntFWmsLk%3D
52. I Takahashi J Matsuda L Gapin H DeWinter Y Kai H Tamagawa, et al. 2002 Colitis-related public T cells are selected in the colonic lamina propria of IL-10-deficient mice Clin Immunol 102 3 237 248 10.1006/clim.2001.5166 11890710 1:CAS:528:DC%2BD38Xjs1Sqtrk%3D (Pubitemid 34259257)